Get the Stockscreener App
24.58
1.76%
-0.44
Doximity Inc stock is traded at $24.58, with a volume of 4.87M.
It is down -1.76% in the last 24 hours and down -40.43% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$25.02
Open:
$25.14
24h Volume:
4.87M
Relative Volume:
1.43
Market Cap:
$4.54B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
24.58
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-9.77%
1M Performance:
-40.43%
6M Performance:
-62.26%
1Y Performance:
-68.11%
1-Day Range:
$24.30
$25.58
1-Week Range:
$24.30
$27.43
52-Week Range:
$23.66
$79.97
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.58 | 4.62B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
176.82 | 28.62B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.56 | 9.24B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.46 | 7.01B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
74.36 | 6.31B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.31 | 4.29B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey
Doximity Inc. (NYSE:DOCS) Fits the "Affordable Growth" Investment Strategy - ChartMill
How Doximity Inc. stock trades before earnings2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru
How Doximity Inc. stock performs in weak economyExit Point & Trade Opportunity Analysis - mfd.ru
Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed? - Yahoo Finance
April 17th Options Now Available For Doximity (DOCS) - Nasdaq
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
Trend Recap: Is Doximity Inc stock suitable for long term investing2025 Market Trends & AI Driven Price Forecasts - baoquankhu1.vn
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Doximity's (NYSE:DOCS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
5 Revealing Analyst Questions From Doximity's Q4 Earnings Call - Finviz
Doximity Stock: Growth Outlook Is Murky (NYSE:DOCS) - Seeking Alpha
Barclays Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
Barclays Has Lowered Expectations for Doximity (NASDAQ:DOCS) Stock Price - MarketBeat
Allianz Asset Management GmbH Invests $5.72 Million in Doximity, Inc. $DOCS - MarketBeat
5 Revealing Analyst Questions From Doximity’s Q4 Earnings Call - The Globe and Mail
Doximity (NASDAQ:DOCS) User Engagement Trends And Nyse Composite Market Reaction Explained - Kalkine Media
Quarterly Trades: Why is Doximity Inc stock going upJuly 2025 Setups & Technical Pattern Alert System - baoquankhu1.vn
Doximity (NASDAQ:DOCS) Price Target Lowered to $34.00 at Mizuho - MarketBeat
Mizuho lowers Doximity stock price target to $34 on pharma marketing delays - Investing.com Nigeria
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Canaccord Genuity Group - MarketBeat
Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader With 60% Upside Potential - DirectorsTalk Interviews
William Blair Dumps $21 Million of Healthcare Platform Doximity Stock - AOL.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Here Are Monday’s Top Wall Street Analyst Research Calls: Autozone, Doximity, Li Auto, Oracle, Robinhood Markets, Roblox, SoFi Technolgy, Terawulf and More - AOL.com
Canaccord Genuity Upgrades Doximity to Buy From Hold, Adjusts Price Target to $34 From $48 - marketscreener.com
Canaccord Genuity upgrades Doximity stock to Buy on valuation By Investing.com - Investing.com UK
Canaccord Genuity upgrades Doximity stock to Buy on valuation - Investing.com
Assessing Doximity (DOCS) Valuation After A Sharp Pullback And Ongoing Profitability - Yahoo Finance
Doximity (DOCS) Earnings Call: AI, Buybacks and Growth - TipRanks
Doximity (NYSE:DOCS) Rating Increased to Moderate Buy at Needham & Company LLC - MarketBeat
Doximity Stock (-17%): Weak Guidance Sparks an Institutional Sell-Off - Trefis
JPMorgan upgrades Doximity stock rating to Neutral from Underweight By Investing.com - Investing.com Nigeria
Truist Securities lowers Doximity stock price target to $37 on growth concerns By Investing.com - Investing.com South Africa
Needham lowers Doximity stock price target to $55 on mixed earnings - Investing.com UK
Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges - FinancialContent
Doximity stock dives as Q4 outlook rattles investors despite $500 million buyback - TechStock²
Doximity, Inc.'s (NYSE:DOCS) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Doximity (NYSE:DOCS) Shares Gap DownWhat's Next? - MarketBeat
Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates - Yahoo Finance
Why Doximity stock plummeted today - MSN
This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Why Doximity Stock Plummeted Today - AOL.com
Doximity's Soft Fiscal Q4 Guidance Adds to Investor Concerns, Morgan Stanley Says - marketscreener.com
Doximity stock price target lowered to $25 by BMO Capital on near-term headwinds - Investing.com Nigeria
Doximity (NASDAQ:DOCS) Shares Gap Down After Analyst Downgrade - MarketBeat
These Stocks Are Today’s Movers: Amazon, Strategy, Novo Nordisk, Molina, Stellantis, Impinj, Doximity, and More - Barron's
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.48%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):